Halozyme Therapeutics
HALO
#2410
Rank
ยฃ4.75 B
Marketcap
ยฃ37.36
Share price
-0.76%
Change (1 day)
28.50%
Change (1 year)

Market capitalization of Halozyme Therapeutics (HALO)

Market cap: ยฃ4.75 Billion

As of December 2024 Halozyme Therapeutics has a market cap of ยฃ4.75 Billion. This makes Halozyme Therapeutics the world's 2410th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Halozyme Therapeutics from 2004 to 2024

End of year Market Cap

Year Marketcap Change
2024ยฃ4.75 B24.03%
2023ยฃ3.83 B-39.74%
2022ยฃ6.35 B51.64%
2021ยฃ4.19 B-0.99%
2020ยฃ4.23 B129.15%
2019ยฃ1.84 B10.82%
2018ยฃ1.66 B-21.84%
2017ยฃ2.13 B105.82%
2016ยฃ1.03 B-30.81%
2015ยฃ1.49 B92.32%
2014ยฃ0.77 B-25.13%
2013ยฃ1.04 B122.44%
2012ยฃ0.46 B-26.25%
2011ยฃ0.63 B22.95%
2010ยฃ0.51 B55.16%
2009ยฃ0.33 B6.87%
2008ยฃ0.31 B11.61%
2007ยฃ0.27 B-1.3%
2006ยฃ0.28 B344.27%
2005ยฃ63.58 M12.77%
2004ยฃ56.38 M

End of Day market cap according to different sources

On Dec 21st, 2024 the market cap of Halozyme Therapeutics was reported to be:

ยฃ4.75 Billion
by Nasdaq info icon info icon
ยฃ4.75 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ยฃ1.50 B-68.38%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ549.32 B 11,456.61%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ11.98 B 152.11%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ118.84 B 2,400.29%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ96.51 B 1,930.38%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ276.72 B 5,721.81%๐Ÿ‡บ๐Ÿ‡ธ USA